Opioid Analgesics Market
Market Insights on Opioid Analgesics covering sales outlook, demand forecast & up-to-date key trends
Opioid Analgesics Market by Drug Class (Morphine, Codeine, Fentanyl, Meperidine, Methadone, Tramadol, Oxycodone, Dextromethorphan, Buprenorphine, Others), Indication (Surgical Pain, Cancer Pain), Route of Administration (Oral, Parenteral, Transdermal, Other), End User & Region - Forecast to 2021 - 2031
Opioid Analgesics Market Snapshot
[315 Pages Report] As per a recent market analysis by Future Market Insights (FMI), demand in the Opioid Analgesics Market is slated to increase at a 5.4% CAGR, reaching a valuation of US$ 39.0 Bn in 2021.
Rising demand for post-surgery pain management and improvements in drug formulations to reduce side effects of analgesics are expected to continue driving sales of Opioid Analgesics over the forecast period.
Sales of morphine are anticipated to command 13% of the overall Opioid Analgesics Market share, and the market valuation is projected to total US$ 65.8 Bn in 2031, opines FMI.
Opioid Analgesics Market Outlook
|
Data Points |
Market Insights |
|
Market Value 2020 |
USD 37.05 Bn |
|
Market Value 2021 |
USD 38.97 Bn |
|
CAGR 2021-2031 |
5.4% |
|
Key Players |
The key players in Opioid Analgesics market are Pfizer Inc, Abbott Laboratories, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH, Bausch Health Companies Inc., and Sanofi S.A. |
Let us know your requirement to get
100% FREE customization
Key Points Covered in Opioid Analgesics Market Survey
- Opioid Analgesics Market estimates and forecast 2021-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Opioid Analgesics Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Opioid Analgesics and how to Navigate
- Recommendation on Key Winning Strategies
Opioid Analgesics Historic Sales Compared to 2021-2031 Forecast Outlook
Demand for opioid analgesics grew at a steady pace, exhibiting a 4.2% CAGR between 2016 and 2020. As per the report, oxycodone had the highest Opioid Analgesics Market share, capturing 19.7% of the total sales recorded in 2020.
Increasing incidence of chronic pain & orthopaedic diseases among the geriatric population is fuelling growth of the opioid analgesics market. Also, rising disposable income and increasing expenditure on healthcare are some factors anticipated to boost growth of the Opioid Analgesics Market during the forecast period.
Opioids are known to be the most effective drugs for pain management. Their utilization in chronic pain management is a standard procedure in many countries across the world.
In response to growing incidence of cancer, orthopaedic diseases and neuropathic pain, demand for opioid analgesics is predicted to grow at a steady pace. FMI has projected the Opioid Analgesics Market to expand at a 5.4% CAGR through 2031.
What are Key Opportunities for Opioid Analgesics Manufacturers?
The convenience and efficacy of opioid analgesics makes them the most preferred drugs for pain management and palliative care. However, to eliminate chances of addiction and overuse, certain regulations are imposed on sales of opioids.
As a result, manufacturers are trying to improve their product offerings by investing in research and development to develop milder and less addictive drugs. This is indicative of lucrative growth opportunities for key opioid analgesics manufacturers.
On the flipside, many people find smaller doses of opioids to be ineffective in treating severe pain. These patients need to take a higher dose of drugs to subdue their pain, which eventually makes them opioid tolerant, and in some cases, addicted to these drugs.
Hence, commercializing opioid-tolerant drugs is anticipated to be one of the main opportunities for manufacturers in the opioid drugs market. This will also help in decreasing the side effects caused by or associated with high consumption of opioid drugs, which in turn, will boost sales of opioid analgesics over the forthcoming years.
How COVID-19 has Impacted Opioid Analgesics Market?
The COVID-19 pandemic has had a negative impact across the medical sector, such as reduction in face-to-face appointments and a rise in telehealth visits. Lockdown restrictions were imposed to control the virus and sustain sufficient capacity in hospitals.
Chronic pain remained one of the toughest-hit fields from the COVID-19 pandemic, leaving most of patients with their ongoing treatment delayed and sustained with their chronic pain.
For example, as per the research article published in 2020, in the Indian Journal of Anesthesia, by Rajendra K Sahoo et a., the study outcomes found that 63.16% of pain doctors had a fear of contracting or spreading the disease to patient families, 1.43% physicians were suffering from depression, 26.79% had impaired sleep, and 8.14% had feelings of anxiety.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWill Increasing Incidence of Opioid Addiction Hinder Sales?
Unavailability of opioids in emerging economies and side effects associated with these drugs are primary factors restraining growth of the opioid analgesics market. Besides this, increasing severity of abusive opioids and their misuse is another major factor hampering growth of the Opioid Analgesics Market.
In addition to this, chronic side effects associated with opioids pose a major challenge for the growth of the Opioid Analgesics Market. For instance, high consumption of morphine can result in severe issue sin the respiratory system, which sometimes can even lead to coma and eventually death. Long-term usage of morphine can result in psychological and physical addiction and could impair the body’s immune system.
Due to increasing misuse of abusive opioids, physicians have reduced their prescription for pain management, which has reduced their overall sale globally. As per the IASP (International Association for the Study of Pain), about 20–30% of opioids given for chronic pain are being misused. In addition to this, around 10% of the total opioid customers are addicted to it.
Rising incidence of opioid abuse is expected to hinder growth of the opioid analgesics market, as physicians are reluctant to prescribe opioids as a pain medication.
Country-wise Insights
What Makes the U.S. an Attractive Opioid Analgesics Market?
The U.S. is projected to dominate the North America opioid analgesics market, holding 86% of the total market share in 2021. Rising prevalence of chronic illnesses and growing consumption of opioids as a pain medication are expected to continue providing tailwinds to sales of opioid analgesics.
Key manufacturers of opioid analgesics in the U.S. are focusing on launching new products to comply with updated regulatory procedures. In addition to this, support from the government-led investments in clinical research will enable the country to continue its dominance over the forecast period.
What will be the Demand Outlook for Opioid Analgesics in Germany?
Sales of opioid analgesics in Germany are projected to rise at a 3.8% CAGR, reaching a valuation of US$ 2.2 Bn in 2021.
Adoption of opioids maintenance treatment (OMT) for treatment of opioids dependence (OD), increasing utilization of non-abusive opioids, and favourable reimbursement programmes offered by German regulatory bodies concerning awareness of palliative care are key factors propelling sales of opioid analgesics in Germany.
Why is Demand for Opioid Analgesics Rising in the U.K.?
The U.K. is projected to lead the Europe opioid analgesics market, with sales growing at a 4.7% CAGR over the forecast period.
The U.K. healthcare system is a well-renowned and universal system, receiving high funding from the government. It is known to be one of the most flourishing and successful healthcare systems among all the countries.
As per our analysis, the U.K. is recognized as the third-dominating Opioid Analgesics Market, and the position is expected to hold over the forecast period. Also, the presence of several major players, growing pipeline drugs, and rising research efforts creates a lucrative opportunities for opioids in the U.K.
Why is China Considered an Emerging Market for Opioid Analgesics?
As per FMI, China is anticipated to lead the East Asia market, accounting for 54.2% of the Opioid Analgesics Market share in 2021. China is dominating the East Asia market owing to increasing utilization of high amounts of opioids for pain management and its extensive manufacturing capacity.
China is the second-largest pharmaceutical market in the world due to rapid productivity and large-scale capital investments in the healthcare sector.
How Will Sales of Opioid Analgesics Fare Across India?
India is expected to hold 35.4% of the South Asia opioid analgesics market share in 2021, with sales growing at a steady 5.7% CAGR.
Small and large pharmaceutical companies in India are actively investing in research and development in response to growing demand for opioid analgesics in the country. A large number of novel drugs in the pipeline are almost at the last stage, and will be available to patients soon.
Presence of government-funded medical and pharmaceutical institutions in India are facilitating clinical trials for opioid analgesics. This surge in the research activities in India is expected to propel the growth of the Opioid Analgesics Market in the forthcoming years
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Why is the Demand for Oxycodone Rising?
Based on drug class, oxycodone is projected to account for a dominant Opioid Analgesics Marketshare of 19.4% in 2021.
Oxycodone is one of the most potent pain relievers available in the Opioid Analgesics Market currently. The drug effectively relieves pain and helps patients to continue their daily tasks. Earlier, oxycodone was not adopted due to unawareness of the constituents and high cost of drugs.
However, rising awareness about the advantages of oxycodone such as more bioavailability is supporting the adoption of the drug.
Usage of Opioid Analgesics for Surgical Pain Relief to Continue Rising
In terms of indication, the surgical pain segment is projected to hold 45.9% of the total Opioid Analgesics Market share due to the rising number of surgical procedures and increasing incidence of associated post-operative pain.
Opioid analgesics are utilized as an effective treatment for pain management after operation or surgery. Increasing adoption of medications for managing and reducing pain is anticipated to propel demand for opioid analgesics over the forecast period.
Sales of Opioid Analgesics through Hospital Pharmacies to Gain Momentum
The hospital pharmacies segment is expected to account for 33.1% of the total Opioid Analgesics Market share in 2021.
Hospitals are considered as major care centres with a strong presence of well–trained staff and professionals that assist patients in effective treatment. Adoption of prescribed therapy in clinics and hospitals aids in supervising drug delivery by a physician. This is one of the key factors driving sales of opioid analgesics through hospital pharmacies.
Competitive Landscape
Key players are focusing on expansion in emerging regions and are launching new and revised products to expand their product portfolios. Product approvals, agreements, partnerships, facility expansion, and strategic collaborations are expected to assist Opioid Analgesics Market players in gaining a competitive edge. For instance:
- In May 2020, Assertio Therapeutics, Inc. merged with Zyla Life Sciences. The merger allowed the companies to expand their product portfolio of neurology, inflammation and chronic pain medications.
- In September 2021, Bausch Health Companies Inc. and its gastroenterology business, Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data at PAINWeek 2021. RELISTOR® (methylnaltrexone bromide) is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain.
Similarly, recent developments related to companies manufacturing opioid analgesics have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Opioid analgesics Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Singapore, China, Japan, South Korea, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
|
Key Market Segments Covered |
Drug Class, Indication, Route of Administration, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Opioid Analgesics Market by Category
By Drug Class:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Tramadol
- Oxycodone
- Dextromethorphan
- Buprenorphine
- Others
By Indication:
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
- Other
By Route of Administration:
- Oral
- Parenteral
- Transdermal
- Other
By End User:
- Hospitals
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA
Frequently Asked Questions
The global opioid analgesics market is anticipated to reach US$ 39.0 Bn in 2021 and is set to expand at 1.7X over the next ten years.
The opioid analgesics market is expected to reach US$ 65.8 Bn by the end of 2031, with sales growing at a 5.4% CAGR.
From 2016-2020, the market for opioid analgesics expanded at a steady 4.2%.
Commercialization of non-abusive opioids, and adoption of opioids maintenance treatment (OMT) to treat opioids dependence (OD), are some of the key trends driving sales of opioid analgesics.
The U.S., Canada, Germany, France, and the U.K. are expected to drive demand for opioid analgesics.
North America is one of the key markets for opioid analgesics, with the U.S. expected to account over 80% of the North America market.
Demand for opioid analgesics in Europe is expected to rise at a steady 5.4% CAGR over the forecast.
The U.S., Germany, the U.K., India, and France are key producers of opioid analgesic.
Japan opioid analgesics market is expected to grow at a 5.6% CAGR, and South Korea is projected to hold 14.5% of the East Asia market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Drug Adoption / Usage Analysis
4.2. Key Strategies Adopted By Manufactures
4.3. Regulatory Scenario
5. Key Inclusion
5.1. Drug Adoption / Usage Analysis
5.2. Key Strategies Adopted By Manufactures
5.3. Regulatory Scenario
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increasing Prevalence of Chronic Disease and Surgical Procedures
6.2.2. Increasing Prevalence of Neuropathic and Chronic pain
6.2.3. Elevating Awareness about Palliative Care and Pain Management
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
6.4. Value Chain Analysis
7. COVID19 Crisis Analysis
7.1.1. Current COVID19 Statistics and Probable Future Impact
7.1.2. Current GDP Projection and Probable Impact
7.1.3. Current Economic Projection as compared to 2008 Economic analysis
7.1.4. COVID19 and Impact Analysis
7.1.4.1. Revenue By Product
7.1.4.2. Revenue By Country
8. Global Analgesics Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031
8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, By Drug Class
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2021–2031
9.3.1. Morphine
9.3.2. Codeine
9.3.3. Fentanyl
9.3.4. Meperidine
9.3.5. Methadone
9.3.6. Tramadol
9.3.7. Oxycodone
9.3.8. Dextromethorphan
9.3.9. Buprenorphine
9.3.10. Others
10. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Indication, 2021 – 2031
10.3.1. Surgical Pain
10.3.2. Cancer Pain
10.3.3. Neuropathic Pain
10.3.4. Other
10.4. Market Attractiveness Analysis By Indications
11. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Route of Administration
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Route of Administration, 2021–2031
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Transdermal
11.3.4. Others
11.4. Market Attractiveness Analysis By Route of Administration
12. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021–2031
12.3.1. Hospitals
12.3.2. Retail Pharmacies
12.3.3. Drug Stores
12.3.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021–2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis By Region
14. North America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
14.3.1. By Drug Class
14.3.2. By Indication
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.3.5. By Country
14.3.5.1. U.S.
14.3.5.2. Canada
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints-Impact Analysis
15. Latin America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
15.3.1. By Drug Class
15.3.2. By Indication
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.3.5. By Country
15.3.5.1. Brazil
15.3.5.2. Mexico
15.3.5.3. Argentina
15.3.5.4. Rest of Latin America
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints-Impact Analysis
16. Europe Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
16.3.1. By Drug Class
16.3.2. By Indication
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.3.5. By Country
16.3.5.1. Germany
16.3.5.2. Italy
16.3.5.3. France
16.3.5.4. U.K.
16.3.5.5. Spain
16.3.5.6. BENELUX
16.3.5.7. Russia
16.3.5.8. Rest of Europe
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints-Impact Analysis
17. South Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
17.3.1. By Drug Class
17.3.2. By Indication
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.3.5. By Country
17.3.5.1. India
17.3.5.2. Thailand
17.3.5.3. Indonesia
17.3.5.4. Malaysia
17.3.5.5. Rest of South Asia
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints-Impact Analysis
18. East Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
18.3.1. By Drug Class
18.3.2. By Indication
18.3.3. By Route of Administration
18.3.4. By Distribution Channel
18.3.5. By Country
18.3.5.1. China
18.3.5.2. Japan
18.3.5.3. South Korea
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints-Impact Analysis
19. Oceania Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
19.3.1. By Drug Class
19.3.2. By Indication
19.3.3. By Route of Administration
19.3.4. By Distribution Channel
19.3.5. By Country
19.3.5.1. Australia
19.3.5.2. New Zealand
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints-Impact Analysis
20. Middle East and Africa Analgesics Market Analysis 2016-2020 and Forecast 2021–2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
20.3.1. By Drug Class
20.3.2. By Indication
20.3.3. By Route of Administration
20.3.4. By Distribution Channel
20.3.5. By Country
20.3.5.1. GCC Countries
20.3.5.2. Turkey
20.3.5.3. Northern Africa
20.3.5.4. South Africa
20.3.5.5. Rest of Middle East and Africa
20.4. Market Attractiveness Analysis
20.5. Drivers and Restraints-Impact Analysis
21. Key and Emerging Countries Analgesics Market Analysis
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Analgesics Market Analysis
21.2.1. By Drug Class
21.2.2. By Indication
21.2.3. By Route of Administration
21.2.4. By Distribution Channel
21.3. Canada Analgesics Market Analysis
21.3.1. By Drug Class
21.3.2. By Indication
21.3.3. By Route of Administration
21.3.4. By Distribution Channel
21.4. Mexico Analgesics Market Analysis
21.4.1. By Drug Class
21.4.2. By Indication
21.4.3. By Route of Administration
21.4.4. By Distribution Channel
21.5. Brazil Analgesics Market Analysis
21.5.1. By Drug Class
21.5.2. By Indication
21.5.3. By Route of Administration
21.5.4. By Distribution Channel
21.6. Germany Analgesics Market Analysis
21.6.1. By Drug Class
21.6.2. By Indication
21.6.3. By Route of Administration
21.6.4. By Distribution Channel
21.7. Italy Analgesics Market Analysis
21.7.1. By Drug Class
21.7.2. By Indication
21.7.3. By Route of Administration
21.7.4. By Distribution Channel
21.8. France Analgesics Market Analysis
21.8.1. By Drug Class
21.8.2. By Indication
21.8.3. By Route of Administration
21.8.4. By Distribution Channel
21.9. U.K. Analgesics Market Analysis
21.9.1. By Drug Class
21.9.2. By Indication
21.9.3. By Route of Administration
21.9.4. By Distribution Channel
21.10. Spain Analgesics Market Analysis
21.10.1. By Drug Class
21.10.2. By Indication
21.10.3. By Route of Administration
21.10.4. By Distribution Channel
21.11. BENELUX Analgesics Market Analysis
21.11.1. By Drug Class
21.11.2. By Indication
21.11.3. By Route of Administration
21.11.4. By Distribution Channel
21.12. Russia Analgesics Market Analysis
21.12.1. By Drug Class
21.12.2. By Indication
21.12.3. By Route of Administration
21.12.4. By Distribution Channel
21.13. China Analgesics Market Analysis
21.13.1. By Drug Class
21.13.2. By Indication
21.13.3. By Route of Administration
21.13.4. By Distribution Channel
21.14. Japan Analgesics Market Analysis
21.14.1. By Drug Class
21.14.2. By Indication
21.14.3. By Route of Administration
21.14.4. By Distribution Channel
21.15. South Korea Analgesics Market Analysis
21.15.1. By Drug Class
21.15.2. By Indication
21.15.3. By Route of Administration
21.15.4. By Distribution Channel
21.16. India Analgesics Market Analysis
21.16.1. By Drug Class
21.16.2. By Indication
21.16.3. By Route of Administration
21.16.4. By Distribution Channel
21.17. ASEAN Analgesics Market Analysis
21.17.1. By Drug Class
21.17.2. By Indication
21.17.3. By Route of Administration
21.17.4. By Distribution Channel
21.18. Australia Analgesics Market Analysis
21.18.1. By Drug Class
21.18.2. By Indication
21.18.3. By Route of Administration
21.18.4. By Distribution Channel
21.19. New Zealand Analgesics Market Analysis
21.19.1. By Drug Class
21.19.2. By Indication
21.19.3. By Route of Administration
21.19.4. By Distribution Channel
21.20. GCC Countries Analgesics Market Analysis
21.20.1. By Drug Class
21.20.2. By Indication
21.20.3. By Route of Administration
21.20.4. By Distribution Channel
21.21. Turkey Analgesics Market Analysis
21.21.1. By Drug Class
21.21.2. By Indication
21.21.3. By Route of Administration
21.21.4. By Distribution Channel
21.22. South Africa Analgesics Market Analysis
21.22.1. By Drug Class
21.22.2. By Indication
21.22.3. By Route of Administration
21.22.4. By Distribution Channel
22. Market Structure Analysis
22.1. Market Share Analysis
22.2. Market Analysis by Tier of Companies
22.3. Market Concentration
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Deep Dive
23.2.1. Pfizer Inc.
23.2.1.1. Overview
23.2.1.2. Product Offering
23.2.1.3. Regional Footprint
23.2.1.4. Strategy Overview
23.2.1.4.1. Marketing Strategy
23.2.1.4.2. Product Strategy
23.2.1.4.3. Channel Strategy
23.2.2. Sun Pharmaceutical Industries, Inc.
23.2.2.1. Overview
23.2.2.2. Product Offering
23.2.2.3. Regional Footprint
23.2.2.4. Strategy Overview
23.2.2.4.1. Marketing Strategy
23.2.2.4.2. Product Strategy
23.2.2.4.3. Channel Strategy
23.2.3. Sanofi SA
23.2.3.1. Overview
23.2.3.2. Product Offering
23.2.3.3. Regional Footprint
23.2.3.4. Strategy Overview
23.2.3.4.1. Marketing Strategy
23.2.3.4.2. Product Strategy
23.2.3.4.3. Channel Strategy
23.2.4. AbbVie Inc. (Allergan plc)
23.2.4.1. Overview
23.2.4.2. Product Offering
23.2.4.3. Regional Footprint
23.2.4.4. Strategy Overview
23.2.4.4.1. Marketing Strategy
23.2.4.4.2. Product Strategy
23.2.4.4.3. Channel Strategy
23.2.5. Teva Pharmaceuticals
23.2.5.1. Overview
23.2.5.2. Product Offering
23.2.5.3. Regional Footprint
23.2.5.4. Strategy Overview
23.2.5.4.1. Marketing Strategy
23.2.5.4.2. Product Strategy
23.2.5.4.3. Channel Strategy
23.2.6. Boehringer Ingelheim International GmbH
23.2.6.1. Overview
23.2.6.2. Product Offering
23.2.6.3. Regional Footprint
23.2.6.4. Strategy Overview
23.2.6.4.1. Marketing Strategy
23.2.6.4.2. Product Strategy
23.2.6.4.3. Channel Strategy
23.2.7. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
23.2.7.1. Overview
23.2.7.2. Product Offering
23.2.7.3. Regional Footprint
23.2.7.4. Strategy Overview
23.2.7.4.1. Marketing Strategy
23.2.7.4.2. Product Strategy
23.2.7.4.3. Channel Strategy
23.2.8. Endo Pharmaceuticals Inc.
23.2.8.1. Overview
23.2.8.2. Product Offering
23.2.8.3. Regional Footprint
23.2.8.4. Strategy Overview
23.2.8.4.1. Marketing Strategy
23.2.8.4.2. Product Strategy
23.2.8.4.3. Channel Strategy
23.2.9. Purdue Pharmaceuticals L.P.
23.2.9.1. Overview
23.2.9.2. Product Offering
23.2.9.3. Regional Footprint
23.2.9.4. Strategy Overview
23.2.9.4.1. Marketing Strategy
23.2.9.4.2. Product Strategy
23.2.9.4.3. Channel Strategy
23.2.10. Assertio Therapeutics, Inc.
23.2.10.1. Overview
23.2.10.2. Product Offering
23.2.10.3. Regional Footprint
23.2.10.4. Strategy Overview
23.2.10.4.1. Marketing Strategy
23.2.10.4.2. Product Strategy
23.2.10.4.3. Channel Strategy
23.2.11. Mallinckrodt Pharmaceuticals
23.2.11.1. Overview
23.2.11.2. Product Offering
23.2.11.3. Regional Footprint
23.2.11.4. Strategy Overview
23.2.11.4.1. Marketing Strategy
23.2.11.4.2. Product Strategy
23.2.11.4.3. Channel Strategy
23.2.12. Bayer AG
23.2.12.1. Overview
23.2.12.2. Product Offering
23.2.12.3. Regional Footprint
23.2.12.4. Strategy Overview
23.2.12.4.1. Marketing Strategy
23.2.12.4.2. Product Strategy
23.2.12.4.3. Channel Strategy
23.2.13. GlaxoSmithKline plc.
23.2.13.1. Overview
23.2.13.2. Product Offering
23.2.13.3. Regional Footprint
23.2.13.4. Strategy Overview
23.2.13.4.1. Marketing Strategy
23.2.13.4.2. Product Strategy
23.2.13.4.3. Channel Strategy
23.2.14. Bausch Health Companies Inc.
23.2.14.1. Overview
23.2.14.2. Product Offering
23.2.14.3. Regional Footprint
23.2.14.4. Strategy Overview
23.2.14.4.1. Marketing Strategy
23.2.14.4.2. Product Strategy
23.2.14.4.3. Channel Strategy
23.2.15. Novartis AG
23.2.15.1. Overview
23.2.15.2. Product Offering
23.2.15.3. Regional Footprint
23.2.15.4. Strategy Overview
23.2.15.4.1. Marketing Strategy
23.2.15.4.2. Product Strategy
23.2.15.4.3. Channel Strategy
23.2.16. Others
23.2.16.1. Overview
23.2.16.2. Product Offering
23.2.16.3. Regional Footprint
23.2.16.4. Strategy Overview
23.2.16.4.1. Marketing Strategy
23.2.16.4.2. Product Strategy
23.2.16.4.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 04: Global Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 05: Global Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 06: Global Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 07: Global Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 08: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 09: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 10: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 11: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 12: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 13: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 15: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 16: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 17: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 18: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 19: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 20: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 21: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 22: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 23: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 24: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 25: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 26: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 27: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 28: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 29: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 30: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 31: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 32: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 33: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 34: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 35: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 36: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 37: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 38: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 39: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 40: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 41: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Table 42: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01 : Global Opioid Analgesics Market Value (US$ Mn) Forecast, 2021 – 2031
Figure 02 : Global Opioid Analgesics Market Share, By Drug Class (2021)
Figure 03 : Global Opioid Analgesics Market Share, By Region (2021)
Figure 04: Global Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 05: Global Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031
Figure 06: Global Opioid Analgesics Market Absolute $ Opportunity Analysis, 2021-2031
Figure 07: Global Opioid Analgesics Market Analysis By Drug Class–2021 & 2031
Figure 08: Global Opioid Analgesics Market Y-o-Y Growth Projections By Drug Class, 2021-2031
Figure 09: Global Opioid Analgesics Market Attractiveness, By Drug Class
Figure 10: Global Opioid Analgesics Market Analysis By Indication–2021 & 2031
Figure 11: Global Opioid Analgesics Market Y-o-Y Growth Projections By Indication, 2021-2031
Figure 12: Global Opioid Analgesics Market Attractiveness, By Indication
Figure 13: Global Opioid Analgesics Market Analysis By Route of Administration – 2021 & 2031
Figure 14: Global Opioid Analgesics Market Y-o-Y Growth Projections By Route of Administration, 2021-2031
Figure 15: Global Opioid Analgesics Market Attractiveness, By Route of Administration
Figure 16: Global Opioid Analgesics Market Analysis By Distribution Channel–2021 & 2031
Figure 17: Global Opioid Analgesics Market Y-o-Y Growth Projections By Distribution Channel, 2021-2031
Figure 18: Global Opioid Analgesics Market Attractiveness, By Distribution Channel
Figure 19: Global Opioid Analgesics Market Analysis by Region–2021 & 2031
Figure 20: Global Opioid Analgesics Market Y-o-Y Growth Projections by Region, 2021-2031
Figure 21: Global Opioid Analgesics Market Attractiveness, By Region
Figure 22: North America Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 23: North America Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 24: North America Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 25: North America Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 26: North America Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 27: North America Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 28: North America Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 29: North America Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 30: North America Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 31: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 32: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 33: North America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 34: Latin America Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 35: Latin America Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 36: Latin America Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 37: Latin America Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 38: Latin America Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 39: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 40: Latin America Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 41: Latin America Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 42: Latin America Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 43: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 44: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 45: Latin America Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 46: Europe Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 47: Europe Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 48: Europe Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 49: Europe Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 50: Europe Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 51: Europe Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 52: Europe Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 53: Europe Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 54: Europe Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 55: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 56: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 57: Europe Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 58: South Asia Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 59: South Asia Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 60: South Asia Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 61: South Asia Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 62: South Asia Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 63: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 64: South Asia Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 65: South Asia Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 66: South Asia Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 67: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 68: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 69: South Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 70: East Asia Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 71: East Asia Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 72: East Asia Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 73: East Asia Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 74: East Asia Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 75: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 76: East Asia Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 77: East Asia Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 78: East Asia Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 79: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 80: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 81: East Asia Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 82: Oceania Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 83: Oceania Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 84: Oceania Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 85: Oceania Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 86: Oceania Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 87: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 88: Oceania Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 89: Oceania Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 90: Oceania Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 91: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 92: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 93: Oceania Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 94: MEA Opioid Analgesics Market Share, By Drug Class, 2021 (E)
Figure 95: MEA Opioid Analgesics Market Share, By Indication, 2021 (E)
Figure 96: MEA Opioid Analgesics Market Share, By Route of Administration, 2021 (E)
Figure 97: MEA Opioid Analgesics Market Share, By Distribution Channel, 2021 (E)
Figure 98: MEA Opioid Analgesics Market Share, By Country, 2021 (E)
Figure 99: MEA Opioid Analgesics Market Size (US$ Mn) Analysis, 2016-2020
Figure 100: MEA Opioid Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 101: MEA Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Country
Figure 102: MEA Opioid Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class
Figure 103: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Figure 104: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
Figure 105: MEA Opioid Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 106: Global Opioid Analgesics Market Value Proportion Analysis, By Emerging Countries, 2020
Figure 107: Opioid Analgesics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031
Figure 108: U.S. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 109: U.S. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 110: U.S. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 111: U.S. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 112: Canada Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 113: Canada Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 114: Canada. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 115: Canada. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 116: Brazil. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 117: Brazil. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 118: Brazil. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 119: Brazil. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 120: Mexico. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 121: Mexico. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 122: Mexico. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 123: Mexico. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 124: UK. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 125: UK. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 126: UK. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 127: UK. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 128: Germany. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 129: Germany. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 130: Germany. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 131: Germany. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 132: Italy. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 133: Italy. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 134: Italy. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 135: Italy. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 136: France. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 137: France. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 138: France. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 139: France. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 140: Spain. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 141: Spain. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 142: Spain. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 143: Spain. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 144: Russia. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 145: Russia. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 146: Russia. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 147: Russia. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 148: BENELUX Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 149: BENELUX Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 150: BENELUX Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 151: BENELUX Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 152: China. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 153: China. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 154: China. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 155: China. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 156: Japan. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 157: Japan. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 158: Japan. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 159: Japan. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 160: South Korea. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 161: South Korea. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 162: South Korea. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 163: South Korea. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 164: India. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 165: India. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 166: India. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 167: India. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 168: Thailand. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 169: Thailand. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 170: Thailand. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 171: Thailand. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 172: Indonesia. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 173: Indonesia. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 174: Indonesia. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 175: Indonesia. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 176: Malaysia. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 177: Malaysia. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 178: Malaysia. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 179: Malaysia. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 180: Australia. Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 181: Australia. Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 182: Australia. Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 183: Australia. Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 184: New Zealand Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 185: New Zealand Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 186: New Zealand Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 187: New Zealand Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 188: Turkey Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 189: Turkey Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 190: Turkey Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 191: Turkey Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 192: GCC Countries Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 193: GCC Countries Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 194: GCC Countries Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 195: GCC Countries Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 196: South Africa Opioid Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031
Figure 197: South Africa Opioid Analgesics Market Share Analysis (%) By Indication, 2021 & 2031
Figure 198: South Africa Opioid Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 199: South Africa Opioid Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
